Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Hair changes can indicate systemic diseases or medication effects.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

ATP helps prevent skin damage from vandetanib by reducing stress.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Warfarin can rarely cause hair loss, which is usually reversible.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Low dose methotrexate does not increase hair fall and may reduce it.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

New treatments for severe alopecia areata show promise but lack standard approval.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.